Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Jul 21, 2023
- Accession no.
- 0001209191-23-043165
- Filed
- Jul 21, 2023
- Trade date
- Jul 19-21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $65.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | Common Stock | MOption exerciseAcquired | +207 | $0.61 | +$126.27 | 528,188 | Direct | |
| Jul 19, 2023 | Common Stock | SSaleDisposed | −207 | $16.08 | −$3,328.56 | 527,981 | Direct | |
| Jul 21, 2023 | Common Stock | MOption exerciseAcquired | +3,900 | $0.61 | +$2,379 | 531,881 | Direct | |
| Jul 21, 2023 | Common Stock | SSaleDisposed | −3,900 | $16.01F2 | −$62,439 | 527,981 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | Common Stock | MOption exerciseDisposed | −207 | $0.00 | $0 | 137,403 | Direct | |
| Jul 21, 2023 | Common Stock | MOption exerciseDisposed | −3,900 | $0.00 | $0 | 133,503 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.07. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Referenced by the price of 1 transaction in Table I.